Endoscopic transpapillary stenting for pancreatic fistulas after necrosectomy with necrotizing pancreatitis.

https://arctichealth.org/en/permalink/ahliterature264301
Source
Surg Endosc. 2015 Jan;29(1):108-12
Publication Type
Article
Date
Jan-2015
Author
Heikki Karjula
Arto Saarela
Anne Vaarala
Jarmo Niemelä
Jyrki Mäkelä
Source
Surg Endosc. 2015 Jan;29(1):108-12
Date
Jan-2015
Language
English
Publication Type
Article
Keywords
Adult
Aged
Cholangiopancreatography, Endoscopic Retrograde
Feasibility Studies
Female
Follow-Up Studies
Humans
Incidence
Male
Middle Aged
Pancreas - surgery
Pancreatic Fistula - epidemiology - etiology - therapy
Pancreatitis, Acute Necrotizing - surgery
Postoperative Complications - epidemiology - therapy
Prospective Studies
Stents
Treatment Outcome
Abstract
Data concerning the incidence and treatment of pancreatic fistula after necrosectomy in severe acute necrotizing pancreatitis (SAP) are scarce. Our aim was to assess the incidence of pancreatic fistula, and the feasibility and results of endoscopic transpapillary stenting (ETS) in patients with SAP after necrosectomy.
From January 2009 to December 2012 twenty-nine consecutive patients with SAP and necrosectomy in Oulu University Hospital were enrolled into this study. Five patients died before ETS because of the rapid progress of the disease and were, therefore, excluded.
ERP was performed for the remaining 24 patients demonstrating fistula in 22/24 patients (92 %). ETS was successful in 23 patients and the fistula closed in all of them after a median of 82 (2-210) days with acceptable morbidity and no procedure-related mortality.
All patients after necrosectomy for SAP seem to have internal or external pancreatic fistula. EST aimed at internal drainage of the necrosectomy cavity is a feasible and effective therapy in these patients.
PubMed ID
24942784 View in PubMed
Less detail